MarketsNotableConfirmed
10.0
Simpar divests Bahia port terminals for R$ 1.8 billion to accelerate deleveraging
Brazil Journal·BR·about 14 hours ago
Goldman Sachs is finalizing an 11-year divestment from Oncoclínicas by selling its remaining 0.7% equity stake through daily market transactions. The bank has systematically offloaded 72 million shares since March, signaling a complete withdrawal from the oncology provider following its 2021 IPO.
Locations
Entities